NCT03673878 (PRURI-C) is a clinical trial in Pruritus, sponsored by University Hospital, Brest.

Who is sponsoring NCT03673878?

NCT03673878 is sponsored by University Hospital, Brest.

What condition does NCT03673878 study?

NCT03673878 studies Pruritus, Brain Tumor.

Is NCT03673878 still recruiting?

NCT03673878 is currently completed. Last updated 27 January 2022.

Last reviewed 2022-01-27 · How we verify

NCT03673878: PRURI-C

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)

Completed Last updated 27 January 2022

What this trial tests

trial in Pruritus in 200 participants. Completed in 5 September 2021.

Timeline

29 June 2020

Primary endpoint
5 September 2021

5 September 2021

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	29 June 2020
Primary completion	5 September 2021
Estimated completion	5 September 2021
Sites	1 location across France

Conditions studied

Pruritus — all drugs for Pruritus →
Brain Tumor — all drugs for Brain Tumor →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Pruritus or Brain Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The association between the presence of pruritus, especially centrofacial, and the presence of a brain tumor is a widespread notion in the medical community but based on a single publication by Andreev et al. in the British Journal of Dermatology published in 1975. No other study has studied this association with a rigorous methodology. The aim of this study is to evaluate the prevalence of pruritus in patients with one or more primary or secondary brain tumor(s), benign(s) or malignant(s).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pruritus and brain tumours: A prospective and descriptive study.
Fardel MA, Brenaut E, Guellec D, Etienne M, et al · · 2023 · cited 3× · PMID 37275426 · DOI 10.1002/ski2.202

Verify or expand the search:

Other recruiting trials for Pruritus

Currently open trials in the same condition.

NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
NCT06751056 — Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch · NA · recruiting
NCT06800755 — Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque · NA · recruiting
NCT06787794 — Reducing Itch With Hypnosis and Virtual Reality · NA · recruiting
NCT06488742 — The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis · NA · recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03673878 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 27 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03673878.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing